Pegzilarginase

Therapeutic indications

Pegzilarginase is indicated for:

Arginase 1 deficiency

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Pegzilarginase is indicated for the treatment of arginase 1 deficiency (ARG1-D), also known as hyperargininemia, in adults, adolescents and children aged 2 years and older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

0.1 mg/kg per week which can be increased or decreased in 0.05 mg/kg increments to achieve therapeutic goals

Contraindications

Pegzilarginase is contraindicated in the following cases:

Pregnancy

Lactation

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.